<DOC>
	<DOCNO>NCT01922999</DOCNO>
	<brief_summary>The study evaluate safety efficacy melatonin supplementation CKD ESRD patient sleep disorder reduce sleep latency time , number apnea/hypopneic episode , prolong duration rapid eye movement ( REM ) sleep CKD ESRD patient sleep disordered breathing .</brief_summary>
	<brief_title>Different Doses Oral Melatonin Supplements Chronic Kidney Disease ( CKD ) -Associated Sleep Disorders</brief_title>
	<detailed_description>The study look safety efficacy melatonin supplementation give patient chronic kidney disease end stage renal disease sleep disorder reduce sleep latency time , number apnea/hypopneic episode , prolong duration rapid eye movement ( REM ) sleep CKD ESRD patient sleep disordered breathing .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>1 . Patient age &gt; 18 &lt; 85 year age 2 . Patients CKD ESRD eGFR &lt; 30 mls/min 3 . If receiving hemodialysis , patient must treatment &gt; 3 month 4 . Normal healthy control must without know history CKD willing formal PSG test plasma melatonin measurement 1 . Patients receive outpatient hemodialysis &lt; 3 month 2 . Patients estimate GFR Cockcroft Gault &gt; 30 mls/min 3 . Patients receive beta blocker therapy within one month randomization 4 . Patients receive Nifedipine therapy within one month randomization 5 . Patients peritoneal dialysis 6 . Patient chronic home oxygen supplementation 7 . Patients receive chronic home CPAP therapy 8 . Patients actively receive outpatient sleep medication 9 . Patients diabetic gastroparesis unresponsive medication 10 . Patients known pregnancy unwilling use contraception course study 11 . Patients function renal allograft 12 . Patient currently receive longterm immunosuppressive therapy . Patients receive low dose prednisone ( 10mg less per day ) exclude trial 13 . Unable give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>